Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research from M.E. Cazzaniga and co-authors yields new data on breast cancer
March 27th, 2008
"The NORA study is a prospective longitudinal cohort study aiming at investigating treatment in patients with early breast cancer. Here, we present the impact of the St Gallen recommendations on clinical practice," scientists in Treviglio, Italy report. "We compared adjuvant strategies in patients enrolled in 2000-2002 to those in 2003-2004 to verify the impact of the 2003 St Gallen recommendations. The use of aromatase inhibitors (Als) doubled: 65/629 patients (10.3%) vs 100/458 patients (21.8) (P < 0.0001). Following chemotherapy, Als were administered in 8.5% of the retrospective cohort and in 15.1 % of the prospective one (P < 0.0001). The use of taxanes plus...
Source: Women's Health Weekly (2008-03-27)
|
